European Archives - Page 379 of 1015 - European Medical Journal

Emetogenicity of Chemotherapy Regimens and Recommended Prophylaxis: A Review of MASCC/ESMO Guidelines

This article reviews the impact of CINV, the emetogenic risk associated with different chemotherapy regimens in solid tumours and haematologic malignancies, and guideline-based recommendations for antiemetic prophylaxis according to emetogenic risk.

Total Plasma Exchange for Hypertriglyceridaemia Complicated by Acute Pancreatitis: A Case Report

Hypertriglyceridaemia pancreatitis (HGTP) accounts for 1–35% of acute pancreatitis (AP) cases.1 Acute pancreatitis is an acute…

The physics of pharmacovigilance

A highly-effective pharmacovigilance function is a rising value differentiator for pharmaceutical companies. Read to find out more about the challenges.

Management of patients with oncogene-driven NSCLC: the shift towards personalized medicine

Management of patients with oncogene-driven NSCLC: the shift towards personalized medicine

Discuss the importance of the implementation of biomarker testing in routine clinical practice and the current and future challenges…

Killing projects, drug discovery and career progression

This week, the GOLD team is joined by Eric Bouilloux, Chief Development Officer, Istesso, to talk about immunometabolism and pharma predictions.

The progress and pain points of patient centricity

The pharmaceutical industry views itself as increasingly patient centric, but do two patient advocates agree? In this roundtable discussion, they consider what the industry is doing well, and their views on how it could improve further

The FutureIBD Meeting Transforming Tomorrows Care

The FutureIBD Meeting: Transforming Tomorrow’s Care

The FutureIBD meeting in Barcelona, Spain, was the first time that leading gastroenterologists had been able to meet face-to-face for quit…

The FutureIBD Meeting: Transforming Tomorrow’s Care

EMJ Gastroenterology 11 [Supplement 2] 2022

The FutureIBD meeting in Barcelona, Spain, was the first time that leading gastroenterologists had been able to meet face-to-face for quite some time due to the challenges of the COVID-19 pandemic. As a result of this, the atmosphere at the meeting was understandably buoyant.

Managing Sleep Disorders

This week, Jonathan sits down with Hugh Selsick, Consultant in Sleep Medicine and Psychiatry at University College London Hospitals, UK.

Editor's Pick: Identifying the Best Ki-67 Cut-Off for Determining Luminal Breast Cancer Subtypes Using Immunohistochemical Analysis and PAM50 Genomic Classification

Over the last few years, advances in molecular biology and genome sequencing have made it possible to identify the genetic alterations that underlie different health conditions, and these advances are particularly important in the field of oncology. Thanks to these advanced techniques, there has been a change in the way a disease as complex and heterogeneous as breast cancer (BC) is understood.